Cardlytics, Inc. (CDLX) shares are progressing more than 26 percent on Monday morning trade announced that it has entered into a settlement agreement with Shareholder Representative Services LLC, or SRS, and successfully resolved all disputes related to the Bridg merger agreement and the earnout payments.
Further, Cardlytics expects to achieve positive adjusted EBITDA for the full year 2023.
Currently, shares are at $7.25, up 25.65 percent from the previous close of $5.77 on a volume of 3,565,672.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.